Please use this identifier to cite or link to this item:
https://doi.org/10.1016/S0041-0101(97)00098-6
DC Field | Value | |
---|---|---|
dc.title | A novel antitumour compound from the mucus of a coral, galaxea fascicularis, inhibits topoisomerase I and II | |
dc.contributor.author | Fung, F.M.Y. | |
dc.contributor.author | Ding, J.L. | |
dc.date.accessioned | 2014-10-27T08:20:00Z | |
dc.date.available | 2014-10-27T08:20:00Z | |
dc.date.issued | 1998-07 | |
dc.identifier.citation | Fung, F.M.Y., Ding, J.L. (1998-07). A novel antitumour compound from the mucus of a coral, galaxea fascicularis, inhibits topoisomerase I and II. Toxicon 36 (7) : 1053-1058. ScholarBank@NUS Repository. https://doi.org/10.1016/S0041-0101(97)00098-6 | |
dc.identifier.issn | 00410101 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/99917 | |
dc.description.abstract | S2 isolated from the mucus of G. fascicularis contains anti- topoisomerase activity, causing cytotoxicity to a multiple-drug resistant leukaemia cell line, P388/VCR. It inhibits DNA relaxation catalysed by topoisomerase I and II. S2 stabilised the topoisomerase I-DNA cleavable complex, thereby inhibiting the DNA replication machinery, leading to cell death. The active centre of S2 probably contains a Galβ(1-4)GlcNAc dissacharide linkage. S2 has potentials of being developed into a new anticancer therapeutic. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S0041-0101(97)00098-6 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | BIOLOGICAL SCIENCES | |
dc.description.doi | 10.1016/S0041-0101(97)00098-6 | |
dc.description.sourcetitle | Toxicon | |
dc.description.volume | 36 | |
dc.description.issue | 7 | |
dc.description.page | 1053-1058 | |
dc.description.coden | TOXIA | |
dc.identifier.isiut | 000074652700010 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.